As we said last night, unknowns and things to watch for that are missing from technical analysis. Ah well, things I said as a super skeptic.
...Finance executives, mostly at Fortune 1000 companies, are concerned that the pandemic could lead to a global economic downturn, disrupting their businesses, reports Mark Maurer for CFO Journal.
Companies around the world are drawing down their credit lines at the same time. Companies said they borrowed the money as a precautionary measure and not because they are currently facing liquidity strains....
(one could say markets are making logical bets but.... ) This is the future and needs to be secured:
...
| |
| 38 AI potential drugs The challenge of finding a drug that works among the thousands of potential candidates is one that artificial intelligence may be well placed to solve, writes Enterprise Technology Editor Steven Rosenbush. XtalPi, a pharmaceutical-technology company that has offices in Shenzhen and Cambridge, Mass. and investors including Tencent and Sequoia China, is trying to winnow down the field. Lipeng Lai, the company’s co-founder and head of AI research, said it has narrowed a list of about 2,900 approved drugs to a 38, using AI to make predictions about how they would perform against the virus. |
No comments:
Post a Comment